Published in J Nucl Med on June 01, 1995
Prediction of functional recovery after revascularization in patients with chronic ischaemic left ventricular dysfunction: head-to-head comparison between 99mTc-sestamibi/18F-FDG DISA SPECT and 13N-ammonia/ 18F-FDG PET. Eur J Nucl Med Mol Imaging (2006) 0.94
Comparison of 99mTc-sestamibi/18FDG DISA SPECT with PET for the detection of viability in patients with coronary artery disease and left ventricular dysfunction. Eur J Nucl Med Mol Imaging (2005) 0.81
Collimation approaches to 511-keV imaging. West J Med (1996) 0.75
Comparison and evaluation of retrospective intermodality brain image registration techniques. J Comput Assist Tomogr (1997) 2.76
Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography. Neurology (1982) 1.99
Analysis of emission tomographic scan data: limitations imposed by resolution and background. J Comput Assist Tomogr (1984) 1.75
Positron emission tomography with F-18-fluorodeoxyglucose to evaluate the results of hepatic chemoembolization. Cancer (1996) 1.69
A host of hypercholesterolaemic homozygotes in South Africa. Br Med J (1980) 1.66
Prospective investigation of positron emission tomography in lung nodules. J Clin Oncol (1998) 1.64
Leptomeningeal carcinomatosis and intramedullary spinal cord metastases from lung cancer: detection with FDG positron emission tomography. Clin Nucl Med (2001) 1.63
Evaluation of benign vs malignant hepatic lesions with positron emission tomography. Arch Surg (1998) 1.63
Staging recurrent metastatic colorectal carcinoma with PET. J Nucl Med (1997) 1.47
Effect of minimally invasive radioguided parathyroidectomy on efficacy, length of stay, and costs in the management of primary hyperparathyroidism. Ann Surg (2000) 1.45
Estimation of left ventricular mass and infarct size from nitrogen-13-ammonia PET images based on pathological examination of explanted human hearts. J Nucl Med (1993) 1.44
Optimal cutoff levels of F-18 fluorodeoxyglucose uptake in the differentiation of low-grade from high-grade brain tumors with PET. Radiology (1995) 1.42
EUS, PET, and CT scanning for evaluation of pancreatic adenocarcinoma. Gastrointest Endosc (2000) 1.41
Correlative pediatric imaging. J Nucl Med (1989) 1.39
18Fluorodeoxyglucose-positron emission tomography in the management of patients with suspected pancreatic cancer. Ann Surg (1999) 1.32
Work in progress: [18F] fluorodeoxyglucose and positron emission tomography in the evaluation of radiation necrosis of the brain. Radiology (1982) 1.31
Evaluation of pulmonary lesions with FDG-PET. Comparison of findings in patients with and without a history of prior malignancy. Chest (1996) 1.29
Computer tomography in basal ganglia calcification. Clin Radiol (1980) 1.26
Retrospective intermodality registration techniques for images of the head: surface-based versus volume-based. IEEE Trans Med Imaging (1999) 1.23
Positron emission tomography to stage suspected metastatic colorectal carcinoma to the liver. Am J Surg (1996) 1.19
Impact of 131I-SPECT/CT images obtained with an integrated system in the follow-up of patients with thyroid carcinoma. Eur J Nucl Med Mol Imaging (2004) 1.14
Tissue signatures with dual-energy computed tomography. Radiology (1979) 1.13
99mTc-HMPAO SPECT imaging in interventional neuroradiology: validation of balloon test occlusion. AJNR Am J Neuroradiol (1992) 1.09
Quantitative vascularity of breast masses by Doppler imaging: regional variations and diagnostic implications. J Ultrasound Med (2000) 1.07
MR imaging and MIBG scintigraphy of pheochromocytomas and extraadrenal functioning paragangliomas. Radiographics (1991) 1.06
Basal ganglia calcification in postoperative hypoparathyroidism. Clin Endocrinol (Oxf) (1980) 1.06
Intrapleural fibrinolytics in management of empyema thoracis. Chest (1996) 1.04
[18F]fluorodeoxyglucose positron emission tomography in refractory complex partial seizures. Ann Neurol (1983) 1.04
Case report. MR and CT appearance of cardiac hemangioma. J Comput Assist Tomogr (1996) 1.04
Clinical history, brain metabolism, and neuropsychological function in Alzheimer's disease. Ann Neurol (1985) 1.03
[FDG-PET/CT in oncology. German Guideline]. Nuklearmedizin (2007) 1.02
Congenital absence of the gallbladder: another cause of false-positive hepatobiliary image. J Nucl Med (1984) 0.96
Evaluation of myocardial ischemia using a rest metabolism/stress perfusion protocol with fluorine-18 deoxyglucose/technetium-99m MIBI and dual-isotope simultaneous-acquisition single-photon emission computed tomography. J Am Coll Cardiol (1995) 0.95
Detection of occult infection following total joint arthroplasty using sequential technetium-99m HDP bone scintigraphy and indium-111 WBC imaging. J Nucl Med (1988) 0.94
Detection of malignancies with SPECT versus PET, with 2-[fluorine-18]fluoro-2-deoxy-D-glucose. Radiology (1996) 0.94
The effect of thyroid hormones on gluconeogenesis and forearm metabolism in man. J Clin Endocrinol Metab (1983) 0.93
Somatostatin receptor imaging: predictive and prognostic considerations. Digestion (1996) 0.93
Evaluating contrast-enhancing brain lesions in patients with AIDS by using positron emission tomography. Ann Intern Med (1995) 0.93
Reduction of infarct size with intracoronary perfluorochemical in a canine preparation of reperfusion. Circulation (1985) 0.92
Renal blood flow changes induced with endothelin-1 and fenoldopam mesylate at quantitative Doppler US: initial results in a canine study. Radiology (2001) 0.91
Isolated intrathoracic presentation of Mycobacterium avium complex in an immunocompetent child. Pediatr Radiol (2001) 0.91
Occult breast carcinoma presenting as an axillary mass. Am Surg (1999) 0.91
Ultrasonic evaluation of fetal ventricular growth. Neuroradiology (1981) 0.91
Image fusion using an integrated, dual-head coincidence camera with X-ray tube-based attenuation maps. J Nucl Med (2000) 0.89
Nuclear medicine case of the day. Hereditary multiple exostoses. AJR Am J Roentgenol (1992) 0.88
Nitrogen-13-ammonia and PET to detect allograft coronary artery disease after heart transplantation: comparison with coronary angiography. J Nucl Med (1995) 0.88
Failure of the three compartment model to describe the pharmacokinetics in brain of a high affinity substituted benzamide. Synapse (1993) 0.87
Recurrent gallbladder carcinoma at laparoscopy port sites diagnosed by positron emission tomography: implications for primary and radical second operations. Am Surg (1997) 0.87
Cat-scratch disease: report of a case with liver lesions and no lymphadenopathy. J Nucl Med (1988) 0.87
Sodium-dependent isomerization of dopamine D-2 receptors characterized using [125I]epidepride, a high-affinity substituted benzamide ligand. J Pharmacol Exp Ther (1990) 0.87
F-18 FDG uptake in a bone infarct: a case report. Clin Nucl Med (2001) 0.86
Synergistic stimulation of prolactin release by phorbol ester, A23187 and forskolin. Biochem Biophys Res Commun (1984) 0.86
Two-dimensional echographic observations in major detachment of a prosthetic aortic valve. Am Heart J (1981) 0.84
Noninvasive detection of acute rejection in a new experimental model of heart transplantation. Ann Thorac Surg (1993) 0.84
Digital subtraction angiography: limitations for the detection of pulmonary embolism. Radiology (1983) 0.84
Novel magnetic technology for intraoperative intracranial frameless navigation: in vivo and in vitro results. Neurosurgery (2001) 0.84
Glucoheptonate measurement of differential renal function. J Urol (1984) 0.84
Gadolinium-enhanced MR angiography. Radiology (1990) 0.83
Treatment of homozygous familial hypercholesterolaemia with portacaval shunt. Atherosclerosis (1982) 0.83
MRI of mumps encephalitis: comparison with CT evaluation. Pediatr Radiol (1987) 0.83
Craniopharyngioma: CT and MR imaging in nine cases. J Comput Assist Tomogr (1987) 0.83
Real-time sonographic detection of vesicoureteral reflux in children. AJR Am J Roentgenol (1982) 0.83
Right ventricular myocardial mass quantification with magnetic resonance imaging. Am J Cardiol (1990) 0.83
Postsurgical outcome of patients with uncontrolled complex partial seizures and temporal lobe hypometabolism on 18FDG-positron emission tomography. Invest Radiol (1996) 0.82
Interreader variability and predictive value of US descriptions of solid breast masses: pilot study. Acad Radiol (2001) 0.82
Down's syndrome in adults: brain metabolism. Science (1983) 0.82
Measurement of blood-brain barrier permeability with positron emission tomography and [68Ga]EDTA. J Cereb Blood Flow Metab (1984) 0.82
Dipyridamole radionuclide ventriculography: a test with high specificity for severe coronary artery disease. J Am Coll Cardiol (1989) 0.82
Positron emission tomography imaging-directed stereotactic neurosurgery. Stereotact Funct Neurosurg (1992) 0.82
18-Fluorodeoxyglucose imaging with positron emission tomography and single photon emission computed tomography: cardiac applications. Semin Nucl Med (2000) 0.82
Correlative radionuclide and magnetic resonance imaging in evaluation of the spine. Clin Nucl Med (1989) 0.81
False-negative cerebral radionuclide flow study, in brain death, caused by a ventricular drain. Clin Nucl Med (1993) 0.81
Hepatocellular carcinoma outcomes based on indicated treatment strategy. Am Surg (1998) 0.81
Positron emission tomography. Prospects for clinical utility. Invest Radiol (1987) 0.81
Kinetics of adenosine 3':5'-monophosphate accumulation in dog thyroid slices. Eur J Biochem (1976) 0.81
Aromatic and amine substituent effects on the apparent lipophilicities of N-[(2-pyrrolidinyl)methyl]-substituted benzamides. J Pharm Sci (1994) 0.80
Fluorine-18-fluorodeoxyglucose cardiac imaging using a modified scintillation camera. J Nucl Med (1998) 0.80
Current status of magnetic resonance imaging. South Med J (1985) 0.80
Esophago-airway fistula in AIDS. Ann Thorac Surg (1995) 0.80
Evaluation of intrathoracic goiter with I-123 scintigraphy and nuclear magnetic resonance imaging. J Nucl Med (1984) 0.80
Dynamic fluctuations in blood and spleen radioactivity: splenic contraction and relation to clinical radionuclide volume calculations. J Am Coll Cardiol (1984) 0.79
A simplified intravenous glucose loading protocol for fluorine-18 fluorodeoxyglucose cardiac single-photon emission tomography. Eur J Nucl Med (1997) 0.79
(S)-N-[(1-ethyl-2-pyrrolidinyl)methyl]-5-[125I]iodo- 2-methoxybenzamide hydrochloride, a new selective radioligand for dopamine D-2 receptors. J Med Chem (1988) 0.79